AstraZeneca delivered 29.8 million Covid vaccine doses to European Union

AstraZeneca has delivered 29.8 million doses of its Covid-19 vaccine to European Union (EU) member states in the first quarter (Q1) of 2021, just "a few doses away" from the promised 30 million

AstraZeneca
AstraZeneca's Covid-19 vaccines | Photo: Reuters
IANS Brussels
1 min read Last Updated : Apr 01 2021 | 1:17 PM IST

AstraZeneca has delivered 29.8 million doses of its Covid-19 vaccine to European Union (EU) member states in the first quarter (Q1) of 2021, just "a few doses away" from the promised 30 million, a European Commission spokesperson said.

EU member states have received 67.5 million doses from BioNTech-Pfizer and 9.8 million doses from Moderna, Xinhua news agency quoted European Commission deputy chief spokesperson Dana Spinant as saying on Wednesday.

These numbers are in line with those announced by European Commission President Ursula Von der Leyen on March 25, with 30 million doses promised by AstraZeneca, 60 million doses by BioNTech-Pfizer, and 10 million doses by Moderna.

AstraZeneca's performance comes as a surprise after delays in production and deliveries from the British-Swedish vaccine manufacturer, which triggered vaccine export control by the EU.

The company's vaccine is also under scrutiny as a few cases of blood clots subsequent to their vaccine's injection were discovered.

However, the European Medicines Agency (EMA) has deemed that the benefits of the vaccine outweigh its risks.

"A causal link with the vaccine is not proven, but is possible and further analysis is continuing," the EMA said in a statement on Wednesday.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :AstraZenecaCoronavirus VaccineEuropean Union

First Published: Apr 01 2021 | 1:14 PM IST

Next Story